How I Treat Acute Lymphoblastic Leukemia with Incorporation of Novel Therapies 


Upon viewing this session, you will be able to:
• Summarize the efficacy and toxicity of novel immunotherapies in acute lymphoblastic leukemia (ALL)
• Review evidence-based treatment approaches for relapsed ALL
• Implement the optimal management for adult patients with ALL


  • Jae Park, MD, Memorial Sloan Kettering Cancer Center


Member Type Price
List Price $30.00
Active, International, Emeritus, and Honorary Members $20.00
Associate, International Associate, Student, and Resident Members $20.00
back to top